Molecular Cancer Research · 2018 · 24 citations · 31 references
MedicineCell BiologyOncologyMetastasisSignal TransductionTumor MicroenvironmentCancer Cell SignalingCellular Responses To HypoxiaHypoxia AdaptationMetastatic Signaling PathwaysOncogenic Signaling PathwaysTumor Microenvironment InteractionsCancer Metastasis MechanismsCell InvasionHypoxia-driven InvasionHypoxia-induced SignalingHypoxic MicroenvironmentPhosphoinositide 3-Kinase-akt ActivationTumor Cell Invasion Under HypoxiaTumor Microenvironment Hypoxia
Abstract Hypoxia, a common feature of solid tumors, has been critically involved in cell invasion and metastasis, but the underlying mechanisms remain poorly understood. Previously, it has been observed that the lysophosphatidic acid receptor 4 (LPA4) signaling axis mediates production of the degradative subcellular structures invadopodia, which are known to be required for metastasis. Here, it is demonstrated that LPA1 (LPAR1) is a common and major receptor used for hypoxia-induced invadopodia production in various cancer cell lines. The widespread use of LPA1 was not due to increased LPA1 expression but rather relied on Src-mediated cross-talk with EGFR. LPA1-mediated phosphorylation of Y845-EGFR under hypoxia led to PI3K/Akt activation, an event that increases the ability of cells to produce invadopodia. Moreover, phospho-Y845-EGFR was upregulated in hypoxic zones of tumors and a combination of EGFR and LPA1 inhibition synergistically suppressed metastasis in vivo. Implications: This study uncovers an LPA1–EGFR signaling axis that is used for cell invasion in hypoxia and suggests a potential target to impede cancer metastasis. Mol Cancer Res; 16(10); 1601–13. ©2018 AACR.
31
Michael Höckel, Karlheinz Schlenger, Bernard Aral et al. · PubMed · 1996 · 1.7K citations
Medicine, Gynecology, Oncology +13
Molecular mechanisms of invadopodium formation
Hideki Yamaguchi, Mike Lorenz, Stephan J. Kempiak et al. · The Journal of Cell Biology · 2005 · 654 citations · Full text
Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors
Hideo Ohta, Kōichi Sato, Naoya Murata et al. · Molecular Pharmacology · 2003 · 402 citations